Sanofi India Ltd share price logo

Sanofi India Share Price

(SANOFI)

₹5168.61.21%

as on 04:01PM, 20 Feb 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Sanofi India Performance

  • Day's Low

    Day's High

    ₹5,142.05
    Day's Price Range
    ₹5,231.7
  • 52 Week's Low

    52 Week's High

    ₹5,058.5
    52-Week Price Range
    ₹10,524.95
1 Month Return-3.17 %
3 Month Return-13.91 %
1 Year Return-42.68 %
Previous Close₹5,231.70
Open₹5,231.70
Volume11.53K
Upper Circuit-
Lower Circuit-
Market Cap₹12,048.61Cr

Sanofi India Key Statistics

P/E Ratio

26.21

PEG Ratio

-10.48

Market Cap

₹12,048.61 Cr

P/B Ratio

18.27

EPS

262.13

Dividend Yield

2.07

Sector

Pharmaceuticals

ROE

52.65

Sanofi India Analyst Rating

based on 3 analysts

BUY

75.00%

Buy

0.00%

Hold

25.00%

Sell

Based on 3 analysts offering long term price targets for Sanofi India. An average target of ₹6927

Source: S&P Global Market Intelligence

Sanofi India Share analysis

Sanofi India price forecast by 3 analysts

Upside of32.40%

High

₹7560

Target

₹6927.00

Low

₹5800

Sanofi India target price ₹6927, a slight upside of 32.4% compared to current price of ₹5168.6. According to 3 analysts rating.

Source: S&P Global Market Intelligence

Key events for Sanofi India Ltd

  • Sanofi India Receives Approval for Rezurock Drug - 10 Feb, 2025

    Sanofi Healthcare India has received marketing authorization for Rezurock (Belumosudil tablets) to treat chronic graft-versus-host disease (cGVHD) in patients aged 12 and above. This approval addresses a significant unmet medical need in the transplant ecosystem, offering a new treatment option for patients who have failed previous therapies.
  • Sanofi India Faces Income Tax Liability Order - 22 Jan, 2025

    Sanofi India disclosed a ₹26.5 crore income tax order related to transfer pricing issues for the assessment year 2022-23. The company plans to appeal the order, stating no material impact on its operations.
  • Sanofi India Reports Mixed Financial Performance - 19 Jan, 2025

    Sanofi India reported FY2024 revenue of Rs. 2,851 crore, a 2.92% increase, but profits fell 2.90% to Rs. 603 crore. The stock price is Rs. 5,440, with a 1-year return of -34.8%.
  • Sanofi India Expands Operations with New Office Lease - 18 Jan, 2025

    Sanofi Healthcare India has leased 270,000 sq ft of office space in Hitech City, Hyderabad, reflecting its commitment to growth in India. The lease, effective January 1, includes a monthly rental of ₹2.05 crore and a five-year lock-in period.

Insights on Sanofi India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 11.00% to 11.04% in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 59.9% return, outperforming this stock by 102.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 60.40% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.1% return, outperforming this stock by 162.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, SANOFI stock has moved down by -42.7%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 5.78% to 5.63% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 11.56% to 11.05% in Dec 2024 quarter

Sanofi India Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹490.70Cr (-)₹693.90Cr (↑41.41%)₹510.80Cr (↓26.39%)₹463.50Cr (↓9.26%)₹524.00Cr (↑13.05%)
Net Income₹151.90Cr (-)₹137.70Cr (↓9.35%)₹136.60Cr (↓0.80%)₹103.20Cr (↓24.45%)₹82.20Cr (↓20.35%)
Net Profit Margin30.96% (-)19.84% (↓35.92%)26.74% (↑34.78%)22.27% (↓16.72%)15.69% (↓29.55%)
Value in ₹ crore
Details2020202120222023
Total Assets₹2,961.50Cr (-)₹3,105.60Cr (↑4.87%)₹2,112.50Cr (↓31.98%)₹1,752.50Cr (↓17.04%)
Total Liabilities₹842.50Cr (-)₹880.00Cr (↑4.45%)₹836.70Cr (↓4.92%)₹737.00Cr (↓11.92%)
Value in ₹ crore
Details20192020202120222023
Operating Cash Flow₹412.30Cr (-)₹611.10Cr (↑48.22%)₹558.80Cr (↓8.56%)₹398.70Cr (↓28.65%)₹230.80Cr (↓42.11%)

Index Inclusions

BSE Healthcare

₹40,263.69

0.4 (159.55%)

S&P BSE 250 SmallCap

₹5,924.26

1.21 (71.08%)

Nifty MidSmallcap 400

₹17,400.70

1.28 (219.75%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Nifty 500

₹20,831.10

0.48 (99.65%)

Nifty Smallcap 250

₹14,767.30

-58.56 (-20868.65%)

S&P BSE 400 MidSmallCap

₹10,582.55

1.23 (128.5%)

BSE 500

₹32,757.57

0.46 (149.8%)

BSE Small-Cap

₹46,054.94

1.32 (599.11%)

Sanofi India Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
60.4%
0.00
Foreign Institutions
5.63%
-2.55
Mutual Funds
11.05%
-4.38
Retail Investors
11.04%
0.31
Others
11.88%
5.51

Sanofi India Key Indicators

Details20042023
Book Value Per Share (₹)189.4441.39
Details20042023
Earning Per Share (₹)65.45262.13
Details20192020202120222023
Return On Equity %19.420.9426.7530.0552.65

Sanofi India Valuation

Sanofi India in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

December 29, 2023

Today (26.21x)

February 19, 2025

Industry (51.87x)

February 19, 2025

Highest (42.25x)

June 12, 2024

LowHigh

Sanofi India Earnings and Dividends

  • Sanofi India Ltd Earnings Results

    Sanofi India Ltd’s net profit fell -45.89% since last year same period to ₹82.20Cr in the Q2 2024-2025. On a quarterly growth basis, Sanofi India Ltd has generated -20.35% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Sanofi India Ltd Dividends February,2024

    In the quarter ending December 2023, Sanofi India Ltd has declared dividend of ₹117 - translating a dividend yield of 10.40%.

    Read More about Dividends

Sanofi India Technicals Summary

Bearish

Neutral

Bullish

Bearish

Sanofi India Ltd is currently in a Bearish trading position according to technical analysis indicators.

Sanofi India Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹12,048.61 Cr-5.69%0.52₹602 Cr₹2,851 Cr
BUY₹66,515.75 Cr17.86%0.56₹3,168 Cr₹29,001 Cr
HOLD₹89,700.73 Cr43.85%0.64₹3,854 Cr₹19,547 Cr
BUY₹63,157.44 Cr18.28%0.53NANA
BUY₹42,474.33 Cr17.29%0.56₹589 Cr₹3,453 Cr

About Sanofi India

Sanofi India Limited (formerly Aventis Pharma) is one of the leading multinational companies (MNCs) in the Indian Pharmaceutical Market. It produces medicines for diabetes, cardiology, thrombosis, epilepsy, allergies, infections, vitamins, central nervous system and antihistamines. Its top products - Lantus, Combiflam, Amaryl and Allegra - feature among the top 100 pharmaceutical brands in India. Sanofi India has 2 own manufacturing facilities in Goa and Ankleshwar in Gujarat and sells products through independent distributors, primarily in India. Sanofi and Hoechst GmbH are the major shareholders of Sanofi India Limited holding 60.4% of its paid-up share capital. In the past few decades, the company has gone through several transformations, launched numerous products and merged/acquired a joint venture and a subsidiary company. In 2020, Sanofi India closed the transaction of slump sale and transfer of its Ankleshwar manufacturing facility to Zentiva Private Limited. In 2021, Sanofi India sold its Nutraceuticals business on a going concern basis to Universal Nutriscience Private Limited for a consideration of ₹5,870 million.

Share Price: ₹5168.60 per share as on 20 Feb, 2025 04:01 PM
Market Capitalisation: ₹12,048.61Cr as of today
Revenue: ₹524.00Cr as on September 2024 (Q3 24)
Net Profit: ₹82.20Cr as on September 2024 (Q3 24)
Listing date: 06 Dec, 1994
Chairperson Name: Aditya Narayan
OrganisationSanofi India
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Sanofi India Ltd

What is Sanofi India Ltd price today?

Sanofi India Ltd share price today stands at ₹5168.6, Open: ₹5231.7, Previous Close: ₹5231.7, High: ₹5231.7, Low: ₹5142.05, 52 Week High: ₹10524.95, 52 Week Low: ₹5058.5.

How to Buy Sanofi India Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Sanofi India Ltd shares

Is Sanofi India Ltd listed on NSE?

Sanofi India Ltd is listed on NSE

Is Sanofi India Ltd listed on BSE?

Sanofi India Ltd is listed on BSE

What are today's High and Low prices of Sanofi India Ltd?

  • Today's highest price of Sanofi India Ltd is ₹5231.7.
  • Today's lowest price of Sanofi India Ltd is ₹5142.05.

What are today's traded volumes of Sanofi India Ltd?

Today's traded volume of Sanofi India Ltd(SANOFI) is 11.53K.

What is today's market capitalisation of Sanofi India Ltd?

Today's market capitalisation of Sanofi India Ltd(SANOFI) is ₹12048.61Cr.

What is the 52 Week High and Low Range of Sanofi India Ltd?

Sanofi India Ltd (SANOFI)
Price
52 Week High
₹10524.95
52 Week Low
₹5058.5

How much percentage Sanofi India Ltd is down from its 52 Week High?

Sanofi India Ltd (SANOFI) share price is ₹5168.6. It is down -50.89% from its 52 Week High price of ₹10524.95

How much percentage Sanofi India Ltd is up from its 52 Week low?

Sanofi India Ltd (SANOFI) share price is ₹5168.6. It is up 2.18% from its 52 Week Low price of ₹5058.5

What are the historical returns of Sanofi India Ltd?

Sanofi India Ltd (SANOFI)
Returns
1 Day Returns
-63.1%
1 Month Returns
-3.17%
3 Month Returns
-13.91%
1 Year Returns
-42.68%

What is the PE ratio of Sanofi India Ltd today?

PE Ratio of Sanofi India Ltd is 26.21

PE ratio = Sanofi India Ltd Market price per share / Sanofi India Ltd Earnings per share